Lv3
250 积分 2023-07-18 加入
Late Recurrence of Completely Resected Stage I-IIIA Lung Adenocarcinoma
1天前
待确认
ROS1-rearranged Non–small-cell Lung Cancer is Associated With a High Rate of Venous Thromboembolism: Analysis From a Phase II, Prospective, Multicenter, Two-arms Trial (METROS)
18天前
已完结
Underlying Mechanisms of Thrombosis Associated with Cancer and Anticancer Therapies
18天前
已完结
Crizotinib inMET-Deregulated orROS1-Rearranged Pretreated Non–Small Cell Lung Cancer (METROS): A Phase II, Prospective, Multicenter, Two-Arms Trial
27天前
已完结
Histopathologic characteristics of advanced-stage ROS1-rearranged non-small cell lung cancers
27天前
已完结
Osimertinib in Resected EGFR -Mutated Non–Small-Cell Lung Cancer
1个月前
已完结
Icotinib versus chemotherapy as adjuvant treatment for stage II–IIIA EGFR-mutant non-small-cell lung cancer (EVIDENCE): a randomised, open-label, phase 3 trial
1个月前
已完结
CNS metastasis in ROS1+ NSCLC: An urgent call to action, to understand, and to overcome
1个月前
已完结
ROS1-dependent cancers — biology, diagnostics and therapeutics
1个月前
已完结
Sacituzumab Tirumotecan in EGFR-TKI–Resistant, EGFR -Mutated Advanced NSCLC
1个月前
已完结
皖公网安备34019202002308
